Weight-loss tamarind and anti-depressants a deadly mix

Image
IANS Washington
Last Updated : Apr 27 2014 | 2:06 PM IST

Are you taking weight-loss supplements while on anti-depressants? Take caution because the popular weight-loss supplement garcinia cambogia -- famously known as Malabar tamarind -- could lead to toxicity in the body.

Previous studies have shown that garcinia cambogia may, in fact, increase the levels of serotonin -- a neurotransmitter.

New research found that taking the supplement in combination with anti-depressants known as selective serotonin reuptake inhibitors (SSRIs) -- which also cause serotonin levels to rise -- could lead to serotonin toxicity.

"People who are taking SSRIs should not use garcinia cambogia at least until further research is done," said D. Robert Hendrickson, a toxicologist at Oregon Health and Sciences University.

In India, garcinia cambogia is better known as Malabar tamarind.

This fruit originated in Indonesia, but is grown and cultivated along the western ghats of Kerala. Sri Lanka and Malaysia are also well acquainted with the garcinia cambogia.

The hydroxycitric acid (HCA) compound in the fruit is touted as a fat-burning, metabolism-boosting, appetite-suppressing weight-loss product.

"If I had a family member or a patient who was considering starting Garcinia and they were on an SSRI, I would recommend that they do not do it for now," a Live Science report quoted Hendrickson as saying.

The study appeared in the Journal of Medical Toxicology.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Apr 27 2014 | 1:58 PM IST

Next Story